Maag Peter's Form 4 filing
CareDx, Inc. (CDNA) · filed Aug 9, 2021
- Accession no.
- 0001217234-21-000196
- Filed
- Aug 9, 2021
- Trade date
- Aug 5, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $831.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maag PeterCIK 0001613855 | Director, Officer (Executive Chair) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Common Stock | SSaleDisposed | −3,096 | $82.81F2 | −$256,379.76 | 356,202 | Direct | |
| Aug 5, 2021 | Common Stock | SSaleDisposed | −6,904 | $83.27F3 | −$574,896.08 | 349,298 | Direct | |
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +3,938 | $12.24 | +$48,201.12 | 353,236 | Direct | |
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +926 | $6.31 | +$5,843.06 | 354,162 | Direct | |
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +94 | $24.35 | +$2,288.9 | 354,256 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +3,938 | $12.24 | +$48,201.12 | 31,250 | Direct | |
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +926 | $6.31 | +$5,843.06 | 10,792 | Direct | |
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +94 | $24.35 | +$2,288.9 | 62,253 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $83.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.01 to $83.75, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.